Default Category
-
Imprimis (B)
Casadesus-Masanell, Ramon; Elterman, Karen; Appel, MarcCase HBS-717496-EEntrepreneurshipThis case is a supplement to Imprimis (Case A). It describes the company's decision to enter into the pharmaceutical compounding business in 2013-14. Imprimis purchased a compounded ophthalmological medication called Dropless Therapy, which was injected into patients' eyes post-cataract surgery, with the aim of replacing a complex regimen of prescription eye drops. After a successful launch of the compounded medication, Imprimis ran into complica...Starting at €5.74
-
The Rise and Rise (?) of Walmart (A): Battling Kmart
Casadesus-Masanell, Ramon; Van Den Steen, Eric; Elterman, KarenCase HBS-718431-EStrategyThis case, set in 1990, describes the history of Walmart and asks what competitive strategies Kmart might adopt in response to Walmart's success. It discusses the strategy and organization of both companies in terms of HR practices, store location, distribution, information technology, procurement, pricing, and company culture. This (A) case is the first in a multi-part series that goes on to describe the results of Kmart's competition with Walma...Starting at €8.20
-
Walmart Ecommerce (A): Picking up the Pace
Casadesus-Masanell, Ramon; Elterman, KarenCase HBS-720425-EStrategyThis case is an abridged version (part 1 of 2) of "Walmart's Omnichannel Strategy: Revolution or Miscalculation?" HBS Case 720-370. The (A) case discusses Walmart's early forays into online retail, as well as improvements made under Doug McMillon beginning in 2014. The case describes Walmart's physical stores, delivery options, grocery business, online marketplace, and distribution system. It also discusses the ecommerce startup Jet.com, which Wa...Starting at €8.20
-
Walmart Ecommerce (B): Omnichannel Pursuits
Casadesus-Masanell, Ramon; Elterman, KarenCase HBS-720426-EStrategyThis case is an abridged version (part 2 of 2) of "Walmart's Omnichannel Strategy: Revolution or Miscalculation?", HBS Case 720-370. The (B) case describes Walmart's omnichannel strategy in 2018 as it battled Amazon for online retail market share. Walmart aimed to integrate its enormous brick and mortar footprint with its growing ecommerce business, e.g., through merchandise and grocery delivery and order online, pickup in store options. It a...Starting at €5.74
-
Steemit: A New Social Media
Casadesus-Masanell, Ramon; White, Alexander; Elterman, KarenCase HBS-720428-EStrategyThis case discusses the alternative social media site Steemit, including the principles it was founded on in 2016 and the challenges it faced in 2019. Steemit was a blockchain-based platform that aimed to differentiate itself from other social media companies by returning power to its users, rather than centralizing control among company executives. Steemit rewarded its users with cryptocurrency for posting, commenting on, and upvoting content on...Starting at €8.20
-
Brazos Partners and Cheddar's Inc., Teaching Note
Hardymon, G. Felda; Lerner, Josh; Leamon, AnnTeaching Note HBS-808055-EFinanceTeaching Note for [806069].Starting at €0.00
-
Hony Capital and Jushi Group
Lerner, Josh; Bernstein, Shai; Leamon, AnnCase HBS-820040-EFinanceHony Capital, a multi-billion dollar private equity firm based in China, is investing in a subsidiary of Jushi Group, a Chinese company that is one of the world's largest fiberglass producers. The specific project will build a plant in the United States. In this case, students consider the value Hony can provide to Jushi, and must also determine how Hony will eventually exit the transaction, given the complexity around its structure.Starting at €8.20
-
Hony Capital and Jushi Group, Teaching Note
Lerner, Josh; Bernstein, Shai; Leamon, AnnTeaching Note HBS-820073-EFinanceThis teaching note accompanies HBS case 820-040, Hony Capital and Jushi Group. John Zhao, CEO of Hony Capital, a China-based private equity (PE) firm with more than $12 billion under management, is considering his firm's investment in Jushi Group, the world's largest fiberglass manufacturer. The transaction has a number of unusual qualities: it is in the unlisted subsidiary of a publicly listed China-based company; Jushi's majority shareholder is...Starting at €0.00
-
Apax Partners and Xerium S.A. (Spanish version)
Hardymon, G. Felda; Lerner, Josh; Leamon, AnnCase HBS-806S01EntrepreneurshipIn 2002, Apax Partners had to decide whether to accept a less-than-perfect offer for one of its portfolio companies or to refinance it. This company, a maker of paper industry consumables with a global presence, had been purchased in 1999 and performed extremely well since then. Despite being a solid, cash-generative operation, it didn't excite a lot of interest in the market. An early exit at a good multiple would be helpful for Apax's current f...Starting at €8.20
-
Imprimis (D)
Casadesus-Masanell, Ramon; Elterman, Karen; Appel, MarcCase HBS-717498-EEntrepreneurshipThis case is a supplement to Imprimis (Case A), Imprimis (Case B), and Imprimis (Case C). It describes Imprimis's 2015 decision to develop a $1 per pill compounded alternative to Daraprim, the branded drug that had recently undergone an extreme price hike, raising its price to $750/pill. Imprimis also created compounded alternatives to several other branded drugs, and made investments to increase its manufacturing capabilities. The company now ha...Starting at €5.74